J&J | JNJ - Aset Lancar





Aset Lancar Perubahan Tanggal
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Baxter International USD 6.99B 142M 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Biogen USD 7.31B 1.88B 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
CONMED USD 675.66M 5.07M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.79B 716M 2026-03
Merck USD 36.68B 1.66B 2026-06
Merit Medical Systems USD 1.11B 10.46M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06
Zoetis USD 6.36B 118M 2026-06